Faust, Christina L. http://orcid.org/0000-0002-8824-7424
Crotti, Marco
Moses, Arinaitwe
Oguttu, David
Wamboko, Aidah
Adriko, Moses
Adekanle, Elizabeth K.
Kabatereine, Narcis
Tukahebwa, Edridah M.
Norton, Alice J.
Gower, Charlotte M.
Webster, Joanne P.
Lamberton, Poppy H. L.
Funding for this research was provided by:
H2020 European Research Council (SCHISTO_PERSIST_680088)
Medical Research Foundation (MR/P025447/1)
Engineering and Physical Sciences Research Council (EP/R01437X/1)
Biotechnology and Biological Sciences Research Council (BB/S013822/1)
Global Challenges Research Fund (MR/S01313X/1)
Research England (CCF-17-7779)
Medical Research Council (PhD studentship)
Wellcome Trust (Biodiversity Fellowship)
Royal Society (University Research Fellowship)
Schistosomiasis Control Initiative
Article History
Received: 10 August 2019
Accepted: 17 December 2019
First Online: 27 December 2019
Ethics approval and consent to participate
: This study was undertaken as part of research conducted by the Schistosomiasis Control Initiative, Imperial College London and the Vector Control Division of the Ministry of Health, Uganda. Methods were approved by the Uganda National Council for Science and Technology (Memorandum of Understanding: sections 1.4, 1.5, 1.6) and the Imperial College Research Ethics Committee (EC NO: 03.36. R&D No: 03/SB/033E). Verbal assent was given by every child before inclusion in the study and at school committee meetings with parents, teachers and community leaders before the onset of the study. Written consent for the children to participate in the study was attained from each head teacher. Participation was voluntary and children could withdraw or be withdrawn from the study at any time. Access to treatment was not dependent on consenting to take part in the study.
: Not applicable.
: The authors declare that they have no competing interests.